BAYER AG
About BAYER AG
Certifications
Categories

-
DE
-
2015On CPHI since
-
4Certificates
-
5000+Employees
CPHI Frankfurt 2025
Messe Frankfurt
Products from BAYER AG (1)
-
Product 1 4-Androstadiene-3 17-Dione (ADD)
Intermediates
BAYER AG Resources (8)
-
News Bayer offers Contract Manufacturing!
You will know Bayer as manufacturer of innovative high-quality API and Drug Products.
But do you know that Bayer offers as well Contract Manufacturing?
Schedule a meeting with us now at CPhI in Frankfurt. We are happy to introduce you to our global manufacturing network with a footprint in Europe, Mexico, China and Japan.
We offer tailored solutions for your product:From Small Molecules to Large Molecules
From classical API synthesis to biocatalysis,
From formulation of semisolids or tableting to aseptic manufacturing of prefilled syringes.
We look forward to hearing from you
-
News CPHI Podcast Series: analysing supplier audits with the PSCI
This episode of the CPHI Podcast Series, hosted by Digital Editor Lucy Chard, goes through the results from the recent audits from the PSCI conducted on suppliers across the pharmaceutical industry, looking into ESG outcomes.
-
News The PSCI introduces the Supplier Maturity Models: a webinar
The PSCI have launched their framework for suppliers in the pharmaceutical and health industry for increasing social and environmental responsibility, complete with guides and resources, all showcased in a helpful webinar.
-
News Allyship in Pharma – Building Industry Inclusivity
Provision of healthcare is an important aspect of people's lives, especially those in the LGBTQIA+ community. Pharmaceutical companies are working to improve this access to medicine and representation for the population.
-
News CPHI Podcast Series: Celebrating International Women’s Day by championing women’s health
The March episode of the CPHI Podcast Series is dedicated to celebrating International Women's Day, followng the theme #EmbraceEquity in the context of women's health.
-
News Viralgen opens expanded AAV manufacturing facility in Spain
The CDMO's fivefold capacity increase will provide early preclinical through to commercialisation support
-
News Bayer makes €250 million manufacturing investment in Finland
The company expects to complete its building and modernising plans in Turku by 2025
-
News Wuxi agrees €150 million deal to buy Wuppertal drug substance facility from Bayer
Acquisition will extend the Chinese CDMO’s European footprint and will complement Leverkusen drug product site